Usefulness of high-sensitivity CRP increases during circadian rhythm for prediction of long-term cardiovascular events in patients with stable coronary artery disease;Kararli koroner arter hastalarinda günlük döngü içinde artiş gösteren yüksek duyarlikli CRP düzeyinin uzun dönem kardiyovasküler olaylari öngörmede kullanilabilirliǧi

Turk Kardiyoloji Dernegi Arsivi

Volumn 39, Issue 7, 2011, Pages 568-575

  Koç, Mevlüt ^a   Şahin, Durmuş Yildiray ^a   Uysal, Onur Kadir ^a   Karaarslan, Osman ^a   Dönmez, Esra ^a   Abali, Gülcan ^a,b   Batur, Mustafa Kemal ^a  

^a ADANA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

Author keywords

Biological markers; C reactive protein; Circadian rhythm; Coronary artery disease; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; BIOLOGICAL MARKER;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART LEFT ATRIUM; HEART LEFT ATRIUM ENDDIASTOLIC DIAMETER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREDICTION; PREDICTIVE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ANGIOCARDIOGRAPHY; BLOOD; EVALUATION; HEART INFARCTION; METABOLISM; MIDDLE AGED; PROGNOSIS; RADIOGRAPHY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84555196263     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2011.01649     Document Type: Article

References (18)

1. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. (Pubitemid 36158034)
2. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418-25. (Pubitemid 32222454)
3. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009;373:1175-82.
4. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65. (Pubitemid 35315836)
5. NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 2009;55:378-84.
6. Koç M, Karaarslan O, Abali G, Batur MK. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease. Tex Heart Inst J 2010;37:42-8.
7. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. (Pubitemid 9091990)
8. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991;84(3 Suppl):I280-7.
9. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996;9:736-60.
10. Ridker PM. Inflammation, high-sensitivity C-reactive protein, and vascular protection. Tex Heart Inst J 2010;37:40-1.
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
12. Bogaty P, Brophy JM, Boyer L, Simard S, Joseph L, Bertrand F, et al. Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med 2005;165:221-6.
13. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007;115:1528-36. (Pubitemid 46648637)
14. Beattie MS, Shlipak MG, Liu H, Browner WS, Schiller NB, Whooley MA. C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study. Circulation 2003;107:245-50. (Pubitemid 36135219)
15. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 2006;47:1018-23.
16. Dini FL, Cortigiani L, Baldini U, Boni A, Nuti R, Barsotti L, et al. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol 2002;89:518-23. (Pubitemid 34178560)
17. de Groote P, Soudan B, Lamblin N, Rouaix-Emery N, Mc Fadden E, Meurice T, et al. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure? Am Heart J 2004;148:349-55. (Pubitemid 39092806)
18. Ristow B, Ali S, Whooley MA, Schiller NB. Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). Am J Cardiol 2008;102:70-6.